Logo image of NTES

NETEASE INC-ADR (NTES) Stock Fundamental Analysis

USA - NASDAQ:NTES - US64110W1027 - ADR

139.19 USD
+1.46 (+1.06%)
Last: 11/18/2025, 5:20:02 PM
139.19 USD
0 (0%)
After Hours: 11/18/2025, 5:20:02 PM
Fundamental Rating

7

We assign a fundamental rating of 7 out of 10 to NTES. NTES was compared to 79 industry peers in the Entertainment industry. NTES has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. NTES may be a bit undervalued, certainly considering the very reasonable score on growth These ratings would make NTES suitable for value and quality investing!


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

In the past year NTES was profitable.
NTES had a positive operating cash flow in the past year.
In the past 5 years NTES has always been profitable.
NTES had a positive operating cash flow in each of the past 5 years.
NTES Yearly Net Income VS EBIT VS OCF VS FCFNTES Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

1.2 Ratios

NTES has a Return On Assets of 16.41%. This is amongst the best in the industry. NTES outperforms 92.41% of its industry peers.
NTES has a better Return On Equity (22.87%) than 88.61% of its industry peers.
NTES's Return On Invested Capital of 17.40% is amongst the best of the industry. NTES outperforms 93.67% of its industry peers.
The Average Return On Invested Capital over the past 3 years for NTES is above the industry average of 9.82%.
The 3 year average ROIC (14.54%) for NTES is below the current ROIC(17.40%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 16.41%
ROE 22.87%
ROIC 17.4%
ROA(3y)14.25%
ROA(5y)12.44%
ROE(3y)21.5%
ROE(5y)19.37%
ROIC(3y)14.54%
ROIC(5y)13.18%
NTES Yearly ROA, ROE, ROICNTES Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

Looking at the Profit Margin, with a value of 31.19%, NTES belongs to the top of the industry, outperforming 97.47% of the companies in the same industry.
NTES's Profit Margin has declined in the last couple of years.
NTES has a better Operating Margin (31.43%) than 98.73% of its industry peers.
NTES's Operating Margin has improved in the last couple of years.
With a decent Gross Margin value of 63.17%, NTES is doing good in the industry, outperforming 70.89% of the companies in the same industry.
NTES's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 31.43%
PM (TTM) 31.19%
GM 63.17%
OM growth 3Y14.45%
OM growth 5Y3.83%
PM growth 3Y13.59%
PM growth 5Y-4.68%
GM growth 3Y5.24%
GM growth 5Y3.25%
NTES Yearly Profit, Operating, Gross MarginsNTES Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

8

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), NTES is creating value.
Compared to 1 year ago, NTES has less shares outstanding
The number of shares outstanding for NTES has been reduced compared to 5 years ago.
The debt/assets ratio for NTES has been reduced compared to a year ago.
NTES Yearly Shares OutstandingNTES Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
NTES Yearly Total Debt VS Total AssetsNTES Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50B 100B 150B

2.2 Solvency

NTES has a debt to FCF ratio of 0.25. This is a very positive value and a sign of high solvency as it would only need 0.25 years to pay back of all of its debts.
NTES has a Debt to FCF ratio of 0.25. This is amongst the best in the industry. NTES outperforms 88.61% of its industry peers.
NTES has a Debt/Equity ratio of 0.08. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.08, NTES is in the better half of the industry, outperforming 60.76% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF 0.25
Altman-Z N/A
ROIC/WACC2.56
WACC6.8%
NTES Yearly LT Debt VS Equity VS FCFNTES Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B 100B

2.3 Liquidity

NTES has a Current Ratio of 3.23. This indicates that NTES is financially healthy and has no problem in meeting its short term obligations.
NTES's Current ratio of 3.23 is amongst the best of the industry. NTES outperforms 89.87% of its industry peers.
NTES has a Quick Ratio of 3.22. This indicates that NTES is financially healthy and has no problem in meeting its short term obligations.
NTES's Quick ratio of 3.22 is amongst the best of the industry. NTES outperforms 89.87% of its industry peers.
Industry RankSector Rank
Current Ratio 3.23
Quick Ratio 3.22
NTES Yearly Current Assets VS Current LiabilitesNTES Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50B 100B 150B

5

3. Growth

3.1 Past

NTES shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 18.55%, which is quite good.
The Earnings Per Share has been growing by 17.51% on average over the past years. This is quite good.
NTES shows a small growth in Revenue. In the last year, the Revenue has grown by 2.74%.
The Revenue has been growing by 12.19% on average over the past years. This is quite good.
EPS 1Y (TTM)18.55%
EPS 3Y21.03%
EPS 5Y17.51%
EPS Q2Q%22.9%
Revenue 1Y (TTM)2.74%
Revenue growth 3Y6.32%
Revenue growth 5Y12.19%
Sales Q2Q%9.44%

3.2 Future

NTES is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -26.15% yearly.
NTES is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 9.66% yearly.
EPS Next Y21.69%
EPS Next 2Y13.82%
EPS Next 3Y12.78%
EPS Next 5Y-26.15%
Revenue Next Year8.55%
Revenue Next 2Y8.14%
Revenue Next 3Y8.42%
Revenue Next 5Y9.66%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
NTES Yearly Revenue VS EstimatesNTES Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 50B 100B 150B 200B
NTES Yearly EPS VS EstimatesNTES Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 20 40 60

8

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 16.75, NTES is valued correctly.
Based on the Price/Earnings ratio, NTES is valued cheaply inside the industry as 83.54% of the companies are valued more expensively.
NTES's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 25.51.
With a Price/Forward Earnings ratio of 14.72, NTES is valued correctly.
Based on the Price/Forward Earnings ratio, NTES is valued cheaply inside the industry as 87.34% of the companies are valued more expensively.
NTES's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 34.98.
Industry RankSector Rank
PE 16.75
Fwd PE 14.72
NTES Price Earnings VS Forward Price EarningsNTES Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

75.95% of the companies in the same industry are more expensive than NTES, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, NTES is valued cheaply inside the industry as 86.08% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 14.4
EV/EBITDA 10.71
NTES Per share dataNTES EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
NTES has an outstanding profitability rating, which may justify a higher PE ratio.
NTES's earnings are expected to grow with 12.78% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.77
PEG (5Y)0.96
EPS Next 2Y13.82%
EPS Next 3Y12.78%

5

5. Dividend

5.1 Amount

NTES has a Yearly Dividend Yield of 2.04%.
NTES's Dividend Yield is rather good when compared to the industry average which is at 41.67. NTES pays more dividend than 91.14% of the companies in the same industry.
NTES's Dividend Yield is comparable with the S&P500 average which is at 2.44.
Industry RankSector Rank
Dividend Yield 2.04%

5.2 History

The dividend of NTES has a limited annual growth rate of 4.94%.
NTES has been paying a dividend for at least 10 years, so it has a reliable track record.
NTES has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)4.94%
Div Incr Years3
Div Non Decr Years3
NTES Yearly Dividends per shareNTES Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2

5.3 Sustainability

36.90% of the earnings are spent on dividend by NTES. This is a low number and sustainable payout ratio.
DP36.9%
EPS Next 2Y13.82%
EPS Next 3Y12.78%
NTES Yearly Income VS Free CF VS DividendNTES Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B
NTES Dividend Payout.NTES Dividend Payout, showing the Payout Ratio.NTES Dividend Payout.PayoutRetained Earnings

NETEASE INC-ADR

NASDAQ:NTES (11/18/2025, 5:20:02 PM)

After market: 139.19 0 (0%)

139.19

+1.46 (+1.06%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)08-14 2025-08-14/bmo
Earnings (Next)11-19 2025-11-19/bmo
Inst Owners9.59%
Inst Owner Change7.79%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap89.71B
Revenue(TTM)109.68B
Net Income(TTM)34.21B
Analysts83.89
Price Target164.19 (17.96%)
Short Float %1.66%
Short Ratio3.27
Dividend
Industry RankSector Rank
Dividend Yield 2.04%
Yearly Dividend2.46
Dividend Growth(5Y)4.94%
DP36.9%
Div Incr Years3
Div Non Decr Years3
Ex-Date08-28 2025-08-28 (0.57)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)10.07%
Min EPS beat(2)-2.68%
Max EPS beat(2)22.83%
EPS beat(4)2
Avg EPS beat(4)6.87%
Min EPS beat(4)-8.86%
Max EPS beat(4)22.83%
EPS beat(8)4
Avg EPS beat(8)4.89%
EPS beat(12)7
Avg EPS beat(12)13.23%
EPS beat(16)10
Avg EPS beat(16)14.05%
Revenue beat(2)0
Avg Revenue beat(2)-2.35%
Min Revenue beat(2)-3.91%
Max Revenue beat(2)-0.78%
Revenue beat(4)0
Avg Revenue beat(4)-3.07%
Min Revenue beat(4)-4.07%
Max Revenue beat(4)-0.78%
Revenue beat(8)0
Avg Revenue beat(8)-3.46%
Revenue beat(12)0
Avg Revenue beat(12)-3.33%
Revenue beat(16)2
Avg Revenue beat(16)-2.21%
PT rev (1m)3.38%
PT rev (3m)10.86%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-0.23%
EPS NY rev (1m)0.08%
EPS NY rev (3m)0.89%
Revenue NQ rev (1m)0.08%
Revenue NQ rev (3m)1.18%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.28%
Valuation
Industry RankSector Rank
PE 16.75
Fwd PE 14.72
P/S 5.81
P/FCF 14.4
P/OCF 13.7
P/B 4.26
P/tB 4.26
EV/EBITDA 10.71
EPS(TTM)8.31
EY5.97%
EPS(NY)9.45
Fwd EY6.79%
FCF(TTM)9.66
FCFY6.94%
OCF(TTM)10.16
OCFY7.3%
SpS23.94
BVpS32.66
TBVpS32.66
PEG (NY)0.77
PEG (5Y)0.96
Graham Number78.14
Profitability
Industry RankSector Rank
ROA 16.41%
ROE 22.87%
ROCE 21.81%
ROIC 17.4%
ROICexc 130.14%
ROICexgc 130.14%
OM 31.43%
PM (TTM) 31.19%
GM 63.17%
FCFM 40.36%
ROA(3y)14.25%
ROA(5y)12.44%
ROE(3y)21.5%
ROE(5y)19.37%
ROIC(3y)14.54%
ROIC(5y)13.18%
ROICexc(3y)98.11%
ROICexc(5y)81.85%
ROICexgc(3y)117.55%
ROICexgc(5y)98.29%
ROCE(3y)19.38%
ROCE(5y)17.87%
ROICexgc growth 3Y31.39%
ROICexgc growth 5Y13.28%
ROICexc growth 3Y29.84%
ROICexc growth 5Y14.27%
OM growth 3Y14.45%
OM growth 5Y3.83%
PM growth 3Y13.59%
PM growth 5Y-4.68%
GM growth 3Y5.24%
GM growth 5Y3.25%
F-Score8
Asset Turnover0.53
Health
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF 0.25
Debt/EBITDA 0.31
Cap/Depr 107.66%
Cap/Sales 2.09%
Interest Coverage 97.92
Cash Conversion 127.21%
Profit Quality 129.41%
Current Ratio 3.23
Quick Ratio 3.22
Altman-Z N/A
F-Score8
WACC6.8%
ROIC/WACC2.56
Cap/Depr(3y)107.89%
Cap/Depr(5y)102.75%
Cap/Sales(3y)2.99%
Cap/Sales(5y)3.4%
Profit Quality(3y)118.33%
Profit Quality(5y)132.69%
High Growth Momentum
Growth
EPS 1Y (TTM)18.55%
EPS 3Y21.03%
EPS 5Y17.51%
EPS Q2Q%22.9%
EPS Next Y21.69%
EPS Next 2Y13.82%
EPS Next 3Y12.78%
EPS Next 5Y-26.15%
Revenue 1Y (TTM)2.74%
Revenue growth 3Y6.32%
Revenue growth 5Y12.19%
Sales Q2Q%9.44%
Revenue Next Year8.55%
Revenue Next 2Y8.14%
Revenue Next 3Y8.42%
Revenue Next 5Y9.66%
EBIT growth 1Y18.69%
EBIT growth 3Y21.69%
EBIT growth 5Y16.49%
EBIT Next Year38.3%
EBIT Next 3Y18.56%
EBIT Next 5Y16.32%
FCF growth 1Y65.97%
FCF growth 3Y19.76%
FCF growth 5Y21.96%
OCF growth 1Y54.29%
OCF growth 3Y16.76%
OCF growth 5Y18.17%

NETEASE INC-ADR / NTES FAQ

What is the ChartMill fundamental rating of NETEASE INC-ADR (NTES) stock?

ChartMill assigns a fundamental rating of 7 / 10 to NTES.


What is the valuation status for NTES stock?

ChartMill assigns a valuation rating of 8 / 10 to NETEASE INC-ADR (NTES). This can be considered as Undervalued.


What is the profitability of NTES stock?

NETEASE INC-ADR (NTES) has a profitability rating of 9 / 10.


How financially healthy is NETEASE INC-ADR?

The financial health rating of NETEASE INC-ADR (NTES) is 8 / 10.


Can you provide the expected EPS growth for NTES stock?

The Earnings per Share (EPS) of NETEASE INC-ADR (NTES) is expected to grow by 21.69% in the next year.